Experience in using levodopa-benserazide
Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper considers the mechanism of action, recommended levodopa doses, the time of therapy initiation, and risk factors for motor complications. A few dosage forms of levodopa are currently being used. The resu...
Main Authors: | Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2015-10-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/538 |
Similar Items
-
Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats
by: Masoud Alirezaei
Published: (2015-10-01) -
Levodopa-induced motor complications associated with benserazide and carbidopa in Parkinson’s disease: a disproportionality analysis of the FAERS database
by: Huaide Qiu, et al.
Published: (2025-03-01) -
Hepatoprotective Effects of Betaine Against Oxidative Stress Induced by Levodopa and Benserazide in Rats
by: M Alirezaei, et al.
Published: (2015-02-01) -
Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease
by: Yifan Yang, et al.
Published: (2023-10-01) -
Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease
by: Dan Su, et al.
Published: (2023-07-01)